Allogeneic tumor-specific cytotoxic T lymphocytes
- PMID: 1371720
- PMCID: PMC11038263
- DOI: 10.1007/BF01741557
Allogeneic tumor-specific cytotoxic T lymphocytes
Abstract
We report the development of cytotoxic T lymphocytes specific for an allogeneic brain tumor in a rat model. DA strain cytotoxic T cell precursors stimulated by an allogeneic tumor (9L gliosarcoma) from the Fischer rat could generate a population of cytotoxic T lymphocytes that lysed the allogeneic 9L tumor but failed to lyse other targets, including Fischer concanavalin-A(ConA)-stimulated lymphoid blast targets. DA T cells depleted of reactivity to the Fischer haplotype (DA-F) retained reactivity to the 9L tumor, demonstrating that T cell precursors with specificity for normal Fischer alloantigens were not required for the generation of a response to the 9L Fischer tumor. The preferential lysis of the tumor target did not simply reflect a higher density of Fischer target antigens on the tumor than that found on normal Fischer ConA blast targets. First, the relative densities of class I antigen on the 9L tumor and normal Fischer ConA blasts were comparable. Second, cytotoxic T cells could not be generated from DA-F precursors when Fischer ConA blasts were used as stimulators. If DA-F T cells were simply responding to the higher density of Fischer antigen found on 9L tumor, it would have been expected that the ConA blasts expressing comparable levels of antigen to that found on the tumor would have generated cytotoxicity for both the 9L and ConA targets. We conclude that the cytotoxic T cells are specific for a determinant expressed only by the tumor. Such tumor-specific cytotoxic T cells could be useful in vivo for adoptive immunotherapy of brain tumors.
Similar articles
-
Gamma interferon transduced 9L gliosarcoma. Cytokine gene therapy and its relevance to cellular therapy with alloreactive cytotoxic T lymphocytes.J Neurooncol. 2003 Aug-Sep;64(1-2):89-99. doi: 10.1007/BF02700024. J Neurooncol. 2003. PMID: 12952290
-
Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.Proc Natl Acad Sci U S A. 1990 Dec;87(24):9577-81. doi: 10.1073/pnas.87.24.9577. Proc Natl Acad Sci U S A. 1990. PMID: 2263613 Free PMC article.
-
Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes.J Interferon Cytokine Res. 2002 Dec;22(12):1209-16. doi: 10.1089/10799900260475731. J Interferon Cytokine Res. 2002. PMID: 12581494
-
Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells.Neurosurgery. 1992 Apr;30(4):499-504; discussion 504-5. doi: 10.1227/00006123-199204000-00005. Neurosurgery. 1992. PMID: 1584347
-
Human cytotoxic T lymphocytes. III. Large numbers of peripheral blood T cells clonally develop into allorestricted anti-viral cytotoxic T cell populations in vitro.J Mol Cell Immunol. 1987;3(1):49-60. J Mol Cell Immunol. 1987. PMID: 2855406
Cited by
-
Implementing preclinical study findings to protocol design: translational studies with alloreactive CTL for gliomas.Am J Transl Res. 2012;4(1):114-26. Epub 2012 Jan 10. Am J Transl Res. 2012. PMID: 22347526 Free PMC article.
-
Immunologic approaches to therapy for brain tumors.Curr Neurol Neurosci Rep. 2001 May;1(3):238-44. doi: 10.1007/s11910-001-0024-8. Curr Neurol Neurosci Rep. 2001. PMID: 11898524 Review.
-
Gamma interferon transduced 9L gliosarcoma. Cytokine gene therapy and its relevance to cellular therapy with alloreactive cytotoxic T lymphocytes.J Neurooncol. 2003 Aug-Sep;64(1-2):89-99. doi: 10.1007/BF02700024. J Neurooncol. 2003. PMID: 12952290
-
Interactions of the allogeneic effector leukemic T cell line, TALL-104, with human malignant brain tumors.Neuro Oncol. 2004 Apr;6(2):83-95. doi: 10.1215/s1152851703000140. Neuro Oncol. 2004. PMID: 15134622 Free PMC article.
-
Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes.J Neurooncol. 1997 Mar;32(1):29-38. doi: 10.1023/a:1005771717409. J Neurooncol. 1997. PMID: 9049860
References
-
- Albright AL, Gill TJ, Geyer SJ. Immunogenetic control of brain tumor growth in rats. Cancer Res. 1977;27:2512. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous